Conventional vs Biologic Therapy in Pediatric IBD
Observational · No treatment assigned · Sites not listed yet · Assiut University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Inflammatory Bowel Diseases, Crohn Disease and Ulcerative Colitis. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Up to age 18
- Any sex
Some of the main requirements, copied from the record:
- \- Confirmed diagnosis of Crohn's disease, ulcerative colitis, or IBD-unclassified according to revised Porto criteria
- Age at diagnosis less than 18 years
- Receipt of conventional therapy and/or biologic therapy for a minimum evaluable treatment duration
Plus 2 more requirement(s). There are also 3 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 100 participants are expected to take part.
- Start date: 2026-09-10 (planned).
- Main results expected around 2027-09-10 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- Clinical remission rate (At week 8-12, 6 months, and 12 months)
In the researchers’ words
This combined retrospective-prospective cohort study aims to evaluate the effectiveness, safety, and adverse events of conventional versus biologic therapy in children and adolescents with inflammatory bowel disease at Assiut University Children Hospital.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis |
| Lead sponsor | Assiut University |
| Enrollment | 100 (estimated) |
| Start date | 2026-09-10 |
| Primary completion (est.) | 2027-09-10 |
| First posted | 2026-09-14 |
| Last updated | 2026-09-14 |
| Official title | Effectiveness, Safety, and Adverse Events of Conventional and Biologic Therapy in Pediatric Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT07818473 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * \- Confirmed diagnosis of Crohn's disease, ulcerative colitis, or IBD-unclassified according to revised Porto criteria * Age at diagnosis less than 18 years * Receipt of conventional therapy and/or biologic therapy for a minimum evaluable treatment duration * Availability of adequate medical records * Written informed consent (for prospective component) Exclusion Criteria: * \- Incomplete medical records precluding assessment of primary endpoints * Age more than 18 years * Discontinuation of follow-up before a minimum evaluable treatment period
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.